Success Metrics

Clinical Success Rate
83.3%

Based on 195 completed trials

Completion Rate
83%(195/234)
Active Trials
188(30%)
Results Posted
39%(76 trials)
Terminated
39(6%)

Phase Distribution

Ph phase_3
115
18%
Ph phase_2
262
42%
Ph early_phase_1
6
1%
Ph phase_1
92
15%
Ph not_applicable
56
9%
Ph phase_4
16
3%

Phase Distribution

98

Early Stage

262

Mid Stage

131

Late Stage

Phase Distribution547 total trials
Early Phase 1First-in-human
6(1.1%)
Phase 1Safety & dosage
92(16.8%)
Phase 2Efficacy & side effects
262(47.9%)
Phase 3Large-scale testing
115(21.0%)
Phase 4Post-market surveillance
16(2.9%)
N/ANon-phased studies
56(10.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.5%

195 of 269 finished

Non-Completion Rate

27.5%

74 ended early

Currently Active

188

trials recruiting

Total Trials

626

all time

Status Distribution
Active(237)
Completed(195)
Terminated(74)
Other(120)

Detailed Status

Completed195
Recruiting153
unknown115
Not yet recruiting46
Terminated39
Active, not recruiting35

Development Timeline

Analytics

Development Status

Total Trials
626
Active
188
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.1%)
Phase 192 (16.8%)
Phase 2262 (47.9%)
Phase 3115 (21.0%)
Phase 416 (2.9%)
N/A56 (10.2%)

Trials by Status

active_not_recruiting356%
recruiting15324%
unknown11518%
withdrawn356%
enrolling_by_invitation30%
not_yet_recruiting467%
suspended51%
terminated396%
completed19531%

Recent Activity

Clinical Trials (626)

Showing 20 of 626 trialsScroll for more
NCT07391774Phase 3

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Recruiting
NCT06090864Phase 1

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Recruiting
NCT04151940Not Applicable

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Recruiting
NCT07613151

Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study

Recruiting
NCT05673148Phase 3

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Recruiting
NCT07293247Phase 2

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Recruiting
NCT06832982Phase 1

Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002

Recruiting
NCT07078604Phase 2

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Recruiting
NCT06949098Phase 2

Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer

Recruiting
NCT06596473Phase 1

A Study of BG-C477 in Participants With Advanced Solid Tumors

Recruiting
NCT04747054Phase 3

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

Recruiting
NCT07392892Phase 2

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Recruiting
NCT06218602Phase 2

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

Recruiting
NCT07476287Phase 2

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Recruiting
NCT07022483Phase 3

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Recruiting
NCT06906887Phase 2

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Recruiting
NCT06529809Phase 1

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

Recruiting
NCT04570423Phase 2

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Recruiting
NCT07168785Early Phase 1

[18F]-AraG PET Imaging in LA HNSCC

Not Yet Recruiting
NCT07222800Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
626